Effect of Metformin and Pioglitazone on Treatment of Psoriasis
4.6 (138 items)
Limited Time Sale$20.17 cheaper than the new price!!
Free cash-on-delivery fees for purchases over $99
Product details
| Management number | 233443634 | Release Date | 2026/06/27 | List Price | $13.45 | Model Number | 233443634 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Psoriasis vulgaris is a common, chronic, relapsing skin disease characterized by predominant involvement of skin, nails and joints. Recent advances in its pathophysiology have shifted the notion of psoriasis from that of a 'disease of the skin' to a 'T-cell mediated systemic disease'. Metformin acts as a modulator of the immune system, in psoriatic patients and has a remarkable effect on the early stages of psoriasis. The activation of PPAR-γ by pioglitazone results in a reduction of the formation of the proinflammatory cytokines, and the inflammatory cells infiltration. These findings support the potential use of PPAR-γ ligands as therapeutic agents in the therapy of conditions associated with autoimmune disease. Read more
| ISBN10 | 3330029455 |
|---|---|
| ISBN13 | 978-3330029453 |
| Language | English |
| Publisher | LAP LAMBERT Academic Publishing |
| Dimensions | 5.91 x 0.13 x 8.66 inches |
| Item Weight | 3.17 ounces |
| Print length | 56 pages |
| Publication date | January 13, 2017 |
Psoriasis
Pilates Rings
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form